RTI Biologics

The markets ended the week closing lower two days in a row. Yet small cap biotech companies RTI Biologics (NASDAQ: RTIX) and STAAR Surgical (NASDAQ: STAA) rose to new 52-week highs of $3.75 and $7.08 per share, respectively, in Friday's trading session. RTI Biologics has been in a very strong...

Benchmark has published a report on RTI Biologics (NASDAQ: RTIX) upgrading the company from Hold to Buy. In the report, Benchmark wrote, "We are upgrading RTIX shares to Buy from Hold based on stronger then anticipated earnings and our view that Spine risks are abating. RTI's performance is...